leadership

James P. Gilligan, Ph.D. MSIB; Co-Founder, Chief Operating Officer

Dr. James Gilligan, a co-founder of Herborium, has over 25 years experience in the pharmaceutical and biotechnology industry. He has nearly 10 years of business experience in China. Dr. Gilligan received his Ph.D. in Pharmacology and Toxicology from the University of Connecticut, during which time he completed a special research fellowship at the Cleveland Clinic Atherosclerosis Research Unit. He performed his post-doctoral training at the Roche Institute of Molecular Biology. Dr. Gilligan is author or co-author of 15 US patents as well as multiple PCT patents and the author of numerous scientific publications. He also received a MS in International Business from Seton Hall University.

Dr. Gilligan is Vice President of Product Development at Unigene Laboratories Inc. Fairfield, NJ, a biopharmaceutical company. He was a founding member of Unigene in 1981 and participated in the design of its R&D facility in 1983 and the cGMP biotechnology manufacturing facility in 1993. His responsibilities have included coordination of all US and international pre-clinical research, toxicology, and regulatory filings as well as design and management of clinical studies. He was an integral part of the team that successfully registered the first “generic” biotechnology product in the EU via a centralized submission. Dr. Gilligan was responsible for coordinating with Warner Lambert (Pfizer) the oral salmon calcitonin program for the treatment and prevention of osteoporosis. He was also responsible for the US program to register and license Fortical Nasal Spray, obtain the Company’s first NDA approval, as well as identifying new applications for Unigene’s technology and negotiations with prospective partners.

Dr. Aihua Qi Vice President, Traditional Chinese Medicine

Dr. Aihua Qi was among the first generation of China’ medical experts who received eight years of interdisciplinary training in both Western medicine and traditional Chinese
medicine (TCM) following the founding of the People's Republic of China. Dr. Qi’s professional experience covers the full spectrum of healthcare including: teaching, research and practice in various renowned academic institutions, hospitals and clinics in the capacity of professor, pharmacist, researcher, and physician. She served in leadership positions in a number of projects focusing on: hepatitis, diabetes, anti-frostbite and cardiovascular diseases at leading Government and Military Hospitals.

Dr. Qi combined her medical training with an entrepreneurship in the late 1980s when she established and operated private medical clinics in the United States and Hong Kong. Over a period of twenty years in addition to private practice she also developed a number of safe and effective drugs based on unique herbal formulations, representing the innovative combination of western methodology and traditional Chinese medicinal theories. In particular she developed novel herbal medicines that improved liver function in patients with chronic hepatic disease. Dr. Qi has also developed a formula that targeted dermatological problems related to acne and Rosacea; this product was recognized by the Chinese Ministry of Health as a drug and was granted an NDA.

Her outstanding contributions to the field of medicine brought her scientific recognitions as the honorary president of Liaoning Traditional Chinese Medicine Institute, adjunct professor at the 302 Hospital of the Chinese People's Liberation Army, editor to the Chinese Journal of Infectious Diseases, and Council Member to the Liaoning Traditional Chinese Medicine Society, among others. Dr. Qi is a graduate of Anshan Medical University where she completed her degree in Western Medicine (1967) and a graduate of Liaoning Traditional Chinese Medical Academic Institute where she specialized in Chinese Medicine.

Max G. Ansbacher - Director; Herborium Board of Directors

Mr. Ansbacher was appointed as our director and as a director of our subsidiary Herborium concurrently with the closing of the merger. He is the principal of Ansbacher Investment Management, a management firm concentrating in sophisticated options strategies. The firm currently manages over $158 million. Prior to founding his firm, Mr. Ansbacher managed options accounts for the investment banking firm Bear Stearns. He is the author of three books on investing and his book The New Options Market is one of the all-time best selling books on exchange traded options. Mr. Ansbacher is a graduate of Phillips Exeter Academy, the University of Vermont and Yale law school. He also holds an advanced degree in tax law from New York University, and is a member of the bar in New York, Vermont and the District of Columbia.

Wayne I. Danson - Director; Herborium Board of Directors

Mr. Danson was appointed as our director and as a director of our subsidiary Herborium concurrently with the closing of the merger. Prior to the merger, Mr. Danson served as Chief Executive Officer and as a director of LW. Mr. Danson was appointed as director of our subsidiary Herborium following the merger. Mr. Danson has served as the Chief Financial Officer of Advanced Communications Technologies, Inc. since December 1, 1999, was appointed a director on January 3, 2000, and appointed President on April 30, 2002. Mr. Danson is the Managing Director and Founder of Danson Partners, LLC, a financial advisory firm specializing in middle market companies in the real estate and technology industries. Prior to forming Danson Partners, LLC in May 1999, Mr. Danson was co-head and Managing Director of PricewaterhouseCoopers LLP's Real Estate Capital Markets Group. Prior to rejoining PricewaterhouseCoopers in 1996, Mr. Danson was a Managing Tax Partner with Kenneth Leventhal & Company in New York and Washington D.C., where he was also Kenneth Leventhal's National Director of its International and Debt Restructure Tax Practices. Prior to his involvement with Kenneth Leventhal in 1988, Mr. Danson was a Managing Director with Wolper Ross & Co., Ltd. in New York, a closely-held financial services company specializing in financial tax, pension consulting, designing financial instruments and providing venture capital and investment banking services. Mr. Danson graduated with honors from Bernard M. Baruch College with a B.B.A. in Accounting and an M.B.A. in Taxation. He is a certified public accountant and a member of the AICPA and the New York State Society of CPAs.